Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 16.41 is in line with its estimated 5-year average of 15.93, around the middle of its estimated 5-year range (4.94–37.65).
As of 2026-10-06T22:23:01.911Z. 62.92% above its estimated 12-month average of 10.07.
Calculation as of: 2026-10-06T22:23:01.911Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 869efbf6e11e98c8b36b953a9b631e7639c239a9e2012f11ad9cca4b0e6b7a7d
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
16.41
PS RATIO AVG TTM
10.07
PS RATIO AVG 3Y
12.29
PS RATIO AVG 5Y
15.93
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+62.92%
CURRENT VS 3Y AVG
+33.57%
CURRENT VS 5Y AVG
+3.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.28
median of 578 covered companies
CURRENT VS SECTOR MEDIAN
+283.86%
vs the sector median at left
Market Cap
$632.16M
PS Ratio
155.21
TTM Avg
124.66
3Y Avg
326.25
5Y Avg
326.25
Market Cap
$656.59M
PS Ratio
7.14
TTM Avg
3326.30
3Y Avg
4783.92
5Y Avg
2925.64
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OmniAb, Inc. (OABI) | $630.63M | 16.41 | 10.07 | 12.29 | 15.93 |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | 155.21 | 124.66 | 326.25 | 326.25 |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $634.30M | 4.66 | 6.00 | 10.10 | 11.53 |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | N/A | N/A | N/A | N/A |
| SOPHiA GENETICS S.A. (SOPH)vs › | $619.15M | 7.19 | 4.88 | 4.31 | 6.09 |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $656.59M | 7.14 | 3326.30 | 4783.92 | 2925.64 |
| Starling Oncology, Inc. (STLN)vs › | $657.89M | 1.12 | 1.06 | 1.06 | 1.06 |
| Annexon, Inc. (ANNX)vs › | $660.29M | N/A | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 1.53 | 1.87 | 2.03 | 3.14 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,239,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $8,375,999 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-04 |
| Q1 FY2026Period ended 2026-03-31 | $14,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $13,415,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $38,429,999 |
Current P/S: $630,630,684 market capitalization ÷ $38,429,999 TTM revenue = 16.41x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 16.41, P/S is near its estimated 5-year median — higher than 62% of readings in its estimated 5-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 5-year low
4.94
median
11.18
estimated 5-year high
37.65
P/S Ratio
16.41
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 16.49 |
| 2026-10-02 | 16.32 |
| 2026-10-01 | 16.72 |
| 2026-09-30 | 16.62 |
| 2026-09-29 | 15.89 |
| 2026-09-28 | 15.89 |
| 2026-09-25 | 15.45 |
| 2026-09-24 | 16.05 |
| 2026-09-23 | 16.05 |
| 2026-09-22 | 16.49 |
| 2026-09-21 | 15.35 |
| 2026-09-18 | 14.98 |
| 2026-09-17 | 14.88 |
| 2026-09-16 | 14.58 |
| 2026-09-15 | 14.58 |
| 2026-09-14 | 15.01 |
| 2026-09-11 | 13.64 |
| 2026-09-10 | 13.24 |
| 2026-09-09 | 13.44 |
| 2026-09-08 | 14.21 |
| 2026-09-04 | 14.51 |
| 2026-09-03 | 15.92 |
| 2026-09-02 | 16.89 |
| 2026-09-01 | 14.88 |
| 2026-08-31 | 14.68 |
| 2026-08-28 | 14.98 |
| 2026-08-27 | 15.45 |
| 2026-08-26 | 16.12 |
| 2026-08-25 | 15.62 |
| 2026-08-24 | 15.79 |
| 2026-08-21 | 14.51 |
| 2026-08-20 | 14.41 |
| 2026-08-19 | 14.04 |
| 2026-08-18 | 13.14 |
| 2026-08-17 | 12.80 |
| 2026-08-14 | 11.33 |
| 2026-08-13 | 11.50 |
| 2026-08-12 | 11.46 |
| 2026-08-11 | 11.33 |
| 2026-08-10 | 11.36 |
| 2026-08-07 | 10.32 |
| 2026-08-06 | 9.94 |
| 2026-08-05 | 9.01 |
| 2026-08-04 | 8.88 |
| 2026-08-03 | 8.70 |
| 2026-07-31 | 8.79 |
| 2026-07-30 | 8.83 |
| 2026-07-29 | 8.66 |
| 2026-07-28 | 8.74 |
| 2026-07-27 | 9.01 |
| 2026-07-24 | 9.01 |
| 2026-07-23 | 9.06 |
| 2026-07-22 | 9.37 |
| 2026-07-21 | 9.28 |
| 2026-07-20 | 9.23 |
| 2026-07-17 | 9.41 |
| 2026-07-16 | 9.06 |
| 2026-07-15 | 9.23 |
| 2026-07-14 | 9.50 |
| 2026-07-13 | 9.37 |
| 2026-07-10 | 10.16 |
| 2026-07-09 | 9.94 |
| 2026-07-08 | 10.21 |
| 2026-07-07 | 10.30 |
| 2026-07-06 | 10.70 |
| 2026-07-02 | 10.74 |
| 2026-07-01 | 10.61 |
| 2026-06-30 | 10.92 |
| 2026-06-29 | 11.41 |
| 2026-06-26 | 11.19 |
| 2026-06-25 | 11.14 |
| 2026-06-24 | 10.12 |
| 2026-06-23 | 10.34 |
| 2026-06-22 | 10.30 |
| 2026-06-18 | 10.39 |
| 2026-06-17 | 9.01 |
| 2026-06-16 | 8.97 |
| 2026-06-15 | 9.37 |
| 2026-06-12 | 10.08 |
| 2026-06-11 | 10.39 |
| 2026-06-10 | 10.56 |
| 2026-06-09 | 10.65 |
| 2026-06-08 | 10.12 |
| 2026-06-05 | 11.01 |
| 2026-06-04 | 11.81 |
| 2026-06-03 | 11.10 |
| 2026-06-02 | 11.63 |
| 2026-06-01 | 11.59 |
| 2026-05-29 | 11.98 |
| 2026-05-28 | 12.07 |
| 2026-05-27 | 11.50 |
| 2026-05-26 | 11.32 |
| 2026-05-22 | 11.76 |
| 2026-05-21 | 11.32 |
| 2026-05-20 | 11.45 |
| 2026-05-19 | 10.52 |
| 2026-05-18 | 10.16 |
| 2026-05-15 | 9.68 |
| 2026-05-14 | 9.72 |
| 2026-05-13 | 8.92 |
| 2026-05-12 | 8.21 |
| 2026-05-11 | 7.41 |
| 2026-05-08 | 7.37 |
| 2026-05-07 | 10.06 |
| 2026-05-06 | 9.79 |
| 2026-05-05 | 9.58 |
| 2026-05-04 | 9.65 |
| 2026-05-01 | 9.58 |
| 2026-04-30 | 9.52 |
| 2026-04-29 | 9.31 |
| 2026-04-28 | 9.58 |
| 2026-04-27 | 9.86 |
| 2026-04-24 | 10.00 |
| 2026-04-23 | 10.68 |
| 2026-04-22 | 10.27 |
| 2026-04-21 | 10.13 |
| 2026-04-20 | 10.61 |
| 2026-04-17 | 11.23 |
| 2026-04-16 | 10.68 |
| 2026-04-15 | 10.13 |
| 2026-04-14 | 10.00 |
| 2026-04-13 | 10.00 |
| 2026-04-10 | 10.06 |
| 2026-04-09 | 10.27 |
| 2026-04-08 | 10.41 |
| 2026-04-07 | 10.34 |
| 2026-04-06 | 10.54 |
| 2026-04-02 | 10.54 |
| 2026-04-01 | 10.68 |
| 2026-03-31 | 10.75 |
| 2026-03-30 | 10.68 |
| 2026-03-27 | 10.34 |
| 2026-03-26 | 10.82 |
| 2026-03-25 | 11.09 |
| 2026-03-24 | 11.43 |
| 2026-03-23 | 12.05 |
| 2026-03-20 | 11.98 |
| 2026-03-19 | 12.60 |
| 2026-03-18 | 12.46 |
| 2026-03-17 | 12.53 |
| 2026-03-16 | 12.53 |
| 2026-03-13 | 12.25 |
| 2026-03-12 | 12.67 |
| 2026-03-11 | 13.42 |
| 2026-03-10 | 13.62 |
| 2026-03-09 | 13.35 |
| 2026-03-06 | 12.94 |
| 2026-03-05 | 13.69 |
| 2026-03-04 | 9.84 |
| 2026-03-03 | 9.41 |
| 2026-03-02 | 9.57 |
| 2026-02-27 | 9.35 |
| 2026-02-26 | 9.79 |
| 2026-02-25 | 9.74 |
| 2026-02-24 | 9.41 |
| 2026-02-23 | 9.30 |
| 2026-02-20 | 9.25 |
| 2026-02-19 | 9.30 |
| 2026-02-18 | 9.30 |
| 2026-02-17 | 9.30 |
| 2026-02-13 | 9.25 |
| 2026-02-12 | 9.19 |
| 2026-02-11 | 9.25 |
| 2026-02-10 | 9.41 |
| 2026-02-09 | 9.74 |
| 2026-02-06 | 9.25 |
| 2026-02-05 | 8.97 |
| 2026-02-04 | 9.46 |
| 2026-02-03 | 9.57 |
| 2026-02-02 | 9.74 |
| 2026-01-30 | 9.90 |
| 2026-01-29 | 10.12 |
| 2026-01-28 | 10.06 |
| 2026-01-27 | 10.66 |
| 2026-01-26 | 10.61 |
| 2026-01-23 | 10.66 |
| 2026-01-22 | 11.26 |
| 2026-01-21 | 10.93 |
| 2026-01-20 | 10.33 |
| 2026-01-16 | 10.33 |
| 2026-01-15 | 10.44 |
| 2026-01-14 | 10.39 |
| 2026-01-13 | 10.33 |
| 2026-01-12 | 10.39 |
| 2026-01-09 | 10.39 |
| 2026-01-08 | 10.28 |
| 2026-01-07 | 10.33 |
| 2026-01-06 | 10.01 |
| 2026-01-05 | 10.06 |
| 2026-01-02 | 10.22 |
| 2025-12-31 | 10.06 |
| 2025-12-30 | 10.12 |
| 2025-12-29 | 10.33 |
| 2025-12-26 | 10.50 |
| 2025-12-24 | 10.66 |
| 2025-12-23 | 10.55 |
| 2025-12-22 | 11.15 |
| 2025-12-19 | 11.37 |
| 2025-12-18 | 10.93 |
| 2025-12-17 | 11.20 |
| 2025-12-16 | 11.15 |
| 2025-12-15 | 11.04 |
| 2025-12-12 | 11.69 |
| 2025-12-11 | 11.75 |
| 2025-12-10 | 10.88 |
| 2025-12-09 | 10.82 |
| 2025-12-08 | 10.82 |
| 2025-12-05 | 10.61 |
| 2025-12-04 | 10.71 |
| 2025-12-03 | 10.22 |
| 2025-12-02 | 9.30 |
| 2025-12-01 | 9.46 |
| 2025-11-28 | 9.84 |
| 2025-11-26 | 10.12 |
| 2025-11-25 | 10.12 |
| 2025-11-24 | 9.41 |
| 2025-11-21 | 9.63 |
| 2025-11-20 | 9.08 |
| 2025-11-19 | 8.97 |
| 2025-11-18 | 8.76 |
| 2025-11-17 | 8.27 |
| 2025-11-14 | 8.48 |
| 2025-11-13 | 8.27 |
| 2025-11-12 | 8.54 |
| 2025-11-11 | 8.76 |
| 2025-11-10 | 8.10 |
| 2025-11-07 | 7.51 |
| 2025-11-06 | 7.51 |
| 2025-11-05 | 7.78 |
| 2025-11-04 | 6.82 |
| 2025-11-03 | 6.82 |
| 2025-10-31 | 7.15 |
| 2025-10-30 | 6.87 |
| 2025-10-29 | 6.78 |
| 2025-10-28 | 7.15 |
| 2025-10-27 | 7.33 |
| 2025-10-24 | 7.51 |
| 2025-10-23 | 7.38 |
| 2025-10-22 | 7.61 |
| 2025-10-21 | 7.65 |
| 2025-10-20 | 7.97 |
| 2025-10-17 | 7.65 |
| 2025-10-16 | 7.84 |
| 2025-10-15 | 7.88 |
| 2025-10-14 | 7.42 |
| 2025-10-13 | 7.47 |
| 2025-10-10 | 7.47 |
| 2025-10-09 | 8.39 |
| 2025-10-08 | 8.07 |
| 2025-10-07 | 7.61 |
| 2025-10-06 | 7.74 |
| 2025-10-03 | 7.51 |
| 2025-10-02 | 7.42 |
| 2025-10-01 | 7.42 |
| 2025-09-30 | 7.38 |
| 2025-09-29 | 7.42 |
| 2025-09-26 | 7.42 |
| 2025-09-25 | 7.19 |
| 2025-09-24 | 7.28 |
| 2025-09-23 | 7.38 |
Showing the most recent 260 of 1,258 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.